Clinical Trial Update: Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating the effect of ridaforolimus on the pharmacokinetics of midazolam in patients with relapsed or refractory advanced cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Advanced Cancer

Drugs mentioned

• Midazolam (Midazolam)
• Ridaforolimus (ridaforolimus)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Relapsed or Refractory Advanced Cancer | Phase 1 | Status: COMPLETED